Global Radiopharmaceuticals Market Research Report: Forecast (2025-2030)

Radiopharmaceuticals Market - By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephr......ology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) and Others, Read more

  • Healthcare
  • Nov 2024
  • 192
  • PDF, Excel, PPT

Market Definition

Radiopharmaceuticals are specialized medications comprising a carrier molecule, often a pharmaceutical agent or biomolecule, combined with a radioactive isotope. These compounds emit radiation that can be detected by imaging devices for diagnostic purposes or deliver targeted radiation therapy to treat diseases, such as cancer.

Market Insights & Analysis: Global Radiopharmaceuticals Market (2025-30):

The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. With the increasing burden of the geriatric population, the incidence of multiple diseases, including cancer, cardiovascular diseases (CVDs), etc., is expected to increase enormously across the world. According to the American Society of Clinical Oncology (ASCO), most people who are diagnosed with cancer are older than 65. As a result, the adoption of radiopharmaceuticals for the diagnosis as well as the treatment of cancer, CVDs, and other diseases would increase, propelling the overall Radiopharmaceuticals Market. For instance, as per the World Health Organisation (WHO), it has been estimated that by 2030, the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. Further, the world’s population of people aged 60 years and older will reach around 2.1 billion by 2050.

Report Coverage Details
  Historical Years   2020-23
  Base Years
  2024
  Forecast Years
  2025-30
  Market Value in 2024   USD 7.11 billion
  Market Value By 2030   USD 12.73 billion
  CAGR (2025-30)   10.19%
  Leading Region   North America
  Top Key Players Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, various awareness programs and initiatives are promoting early disease diagnosis and treatment across the world. These efforts by both government and non-government organizations encourage individuals to undergo regular health check-ups, including full-body screenings, to detect diseases like cancer at early stages when treatment is more effective.

Following that, the adoption of radiopharmaceuticals that have a crucial role to play in various diagnostic procedures, including imaging techniques, like positron emission tomography (PET) scans, which can detect abnormalities & diseases, such as cancer has witnessed a rise. Hence, with that, the Global Radiopharmaceuticals Market is presumed to flourish in the following years.

  1. Market Segmentation
  2. Introduction
    1. Radioisotope Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Radiopharmaceuticals Market Trends & Developments
  5. Global Radiopharmaceuticals Market Dynamics
    1. Drivers
    2. Challenges
  6. Global Radiopharmaceuticals Market Hotspot & Opportunities
  7. Global Radiopharmaceuticals Market Supply Chain Analysis
  8. Global Radiopharmaceuticals Market Regulations and Policy
  9. Global Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Radioisotope
        1. Technetium 99- Market Size & Forecast 2020-2030, USD Million
        2. Fluorine 18- Market Size & Forecast 2020-2030, USD Million
        3. Iodine 131- Market Size & Forecast 2020-2030, USD Million
        4. Gallium 68- Market Size & Forecast 2020-2030, USD Million
        5. Iodine 123- Market Size & Forecast 2020-2030, USD Million
        6. Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
      2. By Indication
        1. Oncology- Market Size & Forecast 2020-2030, USD Million
        2. Cardiology- Market Size & Forecast 2020-2030, USD Million
        3. Gastroenterology- Market Size & Forecast 2020-2030, USD Million
        4. Nephrology- Market Size & Forecast 2020-2030, USD Million
        5. Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
      3. By Type
        1. Diagnostic- Market Size & Forecast 2020-2030, USD Million
        2. Therapeutic- Market Size & Forecast 2020-2030, USD Million
      4. By End User
        1. Hospitals- Market Size & Forecast 2020-2030, USD Million
        2. Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
        3. Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      6. By Competition
        1. Competition Characteristics
        2. Market Share of Companies
  10. North America Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
      2. By Indication- Market Size & Forecast 2020-2030, USD Million
      3. By Type- Market Size & Forecast 2020-2030, USD Million
      4. By End User- Market Size & Forecast 2020-2030, USD Million
      5. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    4. Canada Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    5. Mexico Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
  11. South America Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
      2. By Indication- Market Size & Forecast 2020-2030, USD Million
      3. By Type- Market Size & Forecast 2020-2030, USD Million
      4. By End User- Market Size & Forecast 2020-2030, USD Million
      5. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
  12. Europe Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
      2. By Indication- Market Size & Forecast 2020-2030, USD Million
      3. By Type- Market Size & Forecast 2020-2030, USD Million
      4. By End User- Market Size & Forecast 2020-2030, USD Million
      5. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    4. The UK Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    5. France Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    6. Spain Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    7. Italy Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
  13. The Middle East & Africa Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
      2. By Indication- Market Size & Forecast 2020-2030, USD Million
      3. By Type- Market Size & Forecast 2020-2030, USD Million
      4. By End User- Market Size & Forecast 2020-2030, USD Million
      5. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD MillioN
    4. South Africa Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
  14. Asia-Pacific Radiopharmaceuticals Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
      2. By Indication- Market Size & Forecast 2020-2030, USD Million
      3. By Type- Market Size & Forecast 2020-2030, USD Million
      4. By End User- Market Size & Forecast 2020-2030, USD Million
      5. By Country
        1. China
        2. Japan
        3. Australia
        4. South Korea
        5. India
        6. Rest of Asia-Pacific
    3. China Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    4. Japan Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    5. Australia Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    6. South Korea Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
    7. India Radiopharmaceuticals Market Outlook, 2020-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Radioisotope- Market Size & Forecast 2020-2030, USD Million
        2. By End User- Market Size & Forecast 2020-2030, USD Million
  15. Global Radiopharmaceuticals Market Key Strategic Imperatives for Growth & Success
  16. Competitive Outlook
    1. Company Profiles
      1. Bayer AG
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Iso-Tex Diagnostics, Inc.
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Jubilant Pharmova Limited
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Novartis AG
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. General Electric Company
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Lantheus Holdings, Inc. 
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Eli Lilly and Company
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Siemens Healthineers AG
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Curium Pharma
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Cardinal Health
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Blue Earth Diagnostics, Inc. (Bracco Group)
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Acrotech Biopharm
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Northstar Medical Technologies LLC
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. IBA Radiopharma Solutions 
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Sun Pharmaceutical Industries, Inc.
        1. Business Description
        2. Radioisotope Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying Inquire Before Buying
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization